Stability of Four Commercial Products Delivered by Mail Order
Download in electronic PDF format for $75
Abstract: The purpose of this study was to investigate the stability of
four commercial tablets commonly shipped via mail-order delivery.
The products were: enalapril maleate l0-mg tablets,
digoxin 0.25-mg tablets, clorazepate dipotassium 7.5-mg
tablets and pyridostigmine bromide 60-mg tablets. The stability
studies were conducted at 50°C, and tablets were exposed
for three, seven and 14 days to that temperature. The results
demonstrated that all tablets studied were stable in these conditions
for their exposure time. Therefore, it appears that all
the tablets remained stable and could be used with confidence
in mail-order delivery provided the original product packaging
is not compromised.
Related Keywords:
Samples, Enalapril, Digoxin, Cloazepate, Pyridostigmine
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Four Commercial Products Delivered by Mail Order
Hadzija Boka W, Shrewsbury Robert P
|
Jan/Feb 1999
Pg. 59-63
|
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 474-481
|
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 292-293
|
Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding
Mulder Kyle
|
May/Jun 2021
Pg. 211-216
|
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 462-469
|
How to Handle a Product Recall
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 292-293
|
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 156-160
|
Quality Assurance for Sterile Products
Kastango Eric S, Douglass Kate
|
Jul/Aug 2001
Pg. 246-253
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags
Nalenz Heiko, Köpf Ellen, Dietel Elke
|
Sep/Oct 2018
Pg. 417-423
|
Determining the Availability of a Commercial Drug
|
Jan/Feb 2003
Pg. 44-45
|
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration
Landry Christine, Forest Jean-Marc, Hildgen Patrice
|
Sep/Oct 2005
Pg. 396-298
|
Enalapril Maleate 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 221
|
Autoclaves for the Sterilization of Compounded Parenteral Products
Rahe Hank
|
Mar/Apr 2003
Pg. 114-116
|
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 494
|
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 56
|
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui Ada, Yin Jian, Liu Wei, Zheng Kai
|
May/Jun 2021
Pg. 246-257
|
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
|
Mar/Apr 2016
Pg. 167-174
|
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Alexander Kenneth S, Kothapalli Madhu R, Dollimor David
|
Jan/Feb 1997
Pg. 60-63
|
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
|
May/Jun 2008
Pg. 216-229
|
| Return to Top |
